CGEM - Wall Street Estimates - Cullinan Oncology, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 10.26

1.18 %

$ 597 M

Market Cap

-3.61

P/E

Price Target Average

202.14%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

29.71%

Net Income Estimate

8.04%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Cullinan Oncology, Inc.

Wall Street analysts predict an average 1-year price target for CGEM of $31 , with forecasts ranging from a low of $28 to a high of $38 .

CGEM Lowest Price Target Wall Street Target

28 USD 172.90%

CGEM Average Price Target Wall Street Target

31 USD 202.14%

CGEM Highest Price Target Wall Street Target

38 USD 270.37%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free